Can I read Tirzepatide: Breakthrough Weight Loss Study on EtoBox?

Tirzepatide: Breakthrough Weight Loss Study by joshnivarghese7 is a document available to read on EtoBox.

What is Tirzepatide: Breakthrough Weight Loss Study about?

The SURMOUNT-3 Phase 3 clinical trial demonstrated that tirzepatide significantly enhances weight loss in adults with overweight or obesity, achieving an additional 18.4% weight reduction after a 12-week intensive lifestyle intervention. Compared to placebo and other medications like liraglutide and orlistat, tirzepatide resulted in a higher percentage of participants maintaining their weight loss and reaching weight loss milestones. The safety profile was consistent with earlier trials, showing mild gastro

Author

joshnivarghese7

Language

EN